Seattle Genetics Inc (NASDAQ:SGEN) Director Felix Baker purchased 281,963 shares of Seattle Genetics stock in a transaction dated Wednesday, June 4th. The stock was purchased at an average price of $34.86 per share, for a total transaction of $9,829,230.18. Following the transaction, the director now directly owns 76,997 shares of the company’s stock, valued at approximately $2,684,115. Seattle Genetics, Inc. (NASDAQ:SGEN) net profit margin is -22.30% and weekly performance is 8.86%. On last trading day company shares ended up $37.59. Analysts mean target price for the company is $45.15. Seattle Genetics, Inc. (NASDAQ:SGEN) distance from 50-day simple moving average (SMA50) is -1.04%.
Aegerion Pharmaceuticals Inc (NASDAQ:AEGR) CEO Marc D. Beer bought 10,000 shares of the company’s stock in a transaction dated Tuesday, June 3rd. The shares were purchased at an average price of $30.12 per share, for a total transaction of $301,200.00. Following the acquisition, the chief executive officer now directly owns 69,400 shares of the company’s stock, valued at approximately $2,090,328. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) shares advanced 1.39% in last trading session and ended the day on $33.50. Gross Margin is 89.90% and its return on assets is -44.20%. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) quarterly performance is -33.28%.
Coronado Biosciences Inc (NASDAQ:CNDO) CFO Lucy Lu bought 5,000 shares of the company’s stock in a transaction dated Monday, June 2nd. The shares were purchased at an average price of $ 1.37 per share, for a total transaction of $ 6,850.00. Coronado Biosciences Inc (NASDAQ:CNDO) shares moved up 2.41% in last trading session and was closed at $1.70, while trading in range of $1.63 – $1.70. Coronado Biosciences Inc (NASDAQ:CNDO) year to date (YTD) performance is -35.36%.
OvaScience Inc (NASDAQ:OVAS) Director Harald F Stock bought 1,063 shares of the company’s stock in a transaction dated Wednesday, June 3rd. The shares were purchased at an average price of $ 7.01 per share, for a total transaction of $ 7,451.63. OvaScience Inc (NASDAQ:OVAS) ended the last trading day at $7.58. Company weekly volatility is calculated as 7.07% and price to cash ratio as 2.05. OvaScience Inc (NASDAQ:OVAS) showed a positive weekly performance of 0.26%.